Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Rationale: Changes in the pulmonary microbiota are associated with progressive respiratory diseases including chronic obstructive pulmonary disease (COPD). Whether there is a causal relationship between these changes and disease progression remains unknown. Objectives: To investigate the link between an altered microbiota and disease, we used a murine model of chronic lung inflammation that is characterized by key pathological features found in COPD and compared responses in specific pathogen–free (SPF) mice and mice depleted of microbiota by antibiotic treatment or devoid of a microbiota (axenic). Methods: Mice were challenged with LPS/elastase intranasally over 4 weeks, resulting in a chronically inflamed and damaged lung. The ensuing cellular infiltration, histological damage, and decline in lung function were quantified. Measurements and Main Results: Similar to human disease, the composition of the pulmonary microbiota was altered in diseased animals. We found that the microbiota richness and diversity were decreased in LPS/elastase–treated mice, with an increased representation of the genera Pseudomonas and Lactobacillus and a reduction in Prevotella. Moreover, the microbiota was implicated in disease development as mice depleted, or devoid, of microbiota exhibited an improvement in lung function, reduced inflammation, and lymphoid neogenesis. The absence of microbial cues markedly decreased the production of IL-17A, whereas intranasal transfer of fluid enriched with the pulmonary microbiota isolated from diseased mice enhanced IL-17A production in the lungs of antibiotic-treated or axenic recipients. Finally, in mice harboring a microbiota, neutralizing IL-17A dampened inflammation and restored lung function. Conclusions: Collectively, our data indicate that host–microbial cross-talk promotes inflammation and could underlie the chronicity of inflammatory lung diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“enrichment of Pseudomonas and Lactobacillus in mouse models of chronic lung inflammation,225 or pneumotypeSPT derived from a diseased human bronchoalveolar system,226 is related to an enhanced Th17 type response.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [225]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782 · cited 3×
“Chronic pulmonary inflammation is associated with lymphoid neogenesis, enhanced local antibody responses and IL-17A production In line with previous data in human disease and animal models of CS induced emphysema, (24-27), we observed the formation of lymphoid follicles (LFs) which could be categorized as bronchiolar…”
BackgroundGut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862 · cited 1×
“A further possibility is that the role of the microbiota in promoting disease in our model is due to the gut microbiota, indeed, we have previously reported a gut-lung axis with mice fed a high fiber diet being protected against allergic airway inflammation(63).”
BackgroundSelf-citationThe natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370 · cited 3×
“While patients can manifest mild to severe disease, as defined by the degree of airflow obstruction, the signals leading to increased severity and progression remain unclear (3, 5).”
BackgroundReduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277 · cited 2×
“Alterations in the gut microbiome have been extensively documented for chronic diseases such as inflammatory bowel disease (IBD) (19, 20).”
BackgroundDisordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824 · cited 3×
“Notably, the microbiota in the respiratory tract of healthy volunteers, smokers without COPD and patients with severe disease are distinct (9, 10, 12-14).”
BackgroundGut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577 · cited 5×
“Whether this is due to the cross reactivity between microbial and self-antigens or an indirect effect by the induction of IL-17, as seen in a model of autoimmune arthritis (34), is unknown.”
BackgroundInfluentialGlobal burden of COPD: systematic review and meta-analysis
Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., & Mannino, D. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00124605 · Cited by 1,499 · cited 2×
“Pulmonary emphysema was quantified by measuring mean linear intercept for airspace enlargement and destruction index for alveolar wall destruction(1, 2).”
BackgroundMethodProinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · cited 4×
“In particular, specific bacteria can induce Th17 responses amongst which segmented filamentous bacteria (SFB) have been extensively studied (34, 36).”
BackgroundInfluentialCommensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251 · cited 3×
“Th17 cells (34, 60-62) and exacerbating IL-17 mediated inflammation in experimental autoimmune encephalitis (EAE) and arthritis (34-36).”
BackgroundCompartmentalized Control of Skin Immunity by Resident Commensals
Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M. J., Salcedo, R., Kastenmuller, W., Deming, C., Quinones, M., Koo, L., Conlan, S., et al. (2012) · Science · doi:10.1126/science.1225152 · Cited by 1,092 · cited 1×
“16 microbe interactions localized within a single habitat, such as that found in the lung and skin (55, 56).”
BackgroundAnalysis of the lung microbiome in the “healthy” smoker and in COPD.
Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016384 · Cited by 973 · cited 5×
“Several studies have shown that the composition of the airway microbiota in healthy lungs differs from lungs of patients with COPD, although as yet whether disease creates a habitat for the bacteria, or whether the bacteria cause disease hasn’t been delineated (10, 13, 14).”
BackgroundResultInfluentialLymphoid neogenesis in chronic inflammatory diseases
Aloisi, F., & Pujol-Borrell, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1786 · Cited by 908 · cited 1×
“Lymphoid follicles play a pathological role in several autoimmune diseases by mediating the generation of self-reactive antibodies(23).”
BackgroundBassis, C. M., Erb-Downward, J. R., Dickson, R. P., Freeman, C. M., Schmidt, T. M., Young, V. B., Beck, J. M., Curtis, J. L., & Huffnagle, G. B. (2015) · mBio · doi:10.1128/mbio.00037-15 · Cited by 839 · cited 1×
“Recent studies suggest the pulmonary microbiome originates from the dispersal of microbes from the nasal and oral cavities (58, 59).”
BackgroundMartin, B., Hirota, K., Cua, D. J., Stockinger, B., & Veldhoen, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.020 · Cited by 822 · cited 1×
“Th17 cells (34, 60-62) and exacerbating IL-17 mediated inflammation in experimental autoimmune encephalitis (EAE) and arthritis (34-36).”
BackgroundMediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710 · cited 1×
“In spite of the heterogeneity in human disease, it is apparent that aberrant inflammatory responses substantially contribute to the decline in lung function (5-7).”
BackgroundAntielastin autoimmunity in tobacco smoking–induced emphysema
Lee, S.-H., Goswami, S., Grudo, A., Song, L.-Z., Bandi, V., Goodnight-White, S., Green, L., Hacken-Bitar, J., Huh, J., Bakaeen, F., et al. (2007) · Nature Medicine · doi:10.1038/nm1583 · Cited by 593 · cited 3×
“While sequence analysis of B cell clones isolated from LFs in COPD lungs has indicated the presence of an oligoclonal, antigen specific humoral response (25), there are conflicting reports regarding the production of self-reactive antibodies (28-32).”
BackgroundThe Lung Tissue Microbiome in Chronic Obstructive Pulmonary Disease
Sze, M. A., Dimitriu, P. A., Hayashi, S., Elliott, W. M., McDonough, J. E., Gosselink, J. V., Cooper, J., Sin, D. D., Mohn, W. W., & Hogg, J. C. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2075oc · Cited by 552 · cited 5×
“Several studies have shown that the composition of the airway microbiota in healthy lungs differs from lungs of patients with COPD, although as yet whether disease creates a habitat for the bacteria, or whether the bacteria cause disease hasn’t been delineated (10, 13, 14).”
BackgroundInfluentialThe role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495 · cited 1×
“Previously considered sterile, breakthroughs in non-culture based detection methods have provided evidence that the respiratory tract harbors a microbiota (9-18).”
BackgroundAlveolar inflammation and its relation to emphysema in smokers.
Finkelstein, R., Fraser, R. S., Ghezzo, H., & Cosio, M. G. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.5.7582312 · Cited by 483 · cited 1×
“In spite of the heterogeneity in human disease, it is apparent that aberrant inflammatory responses substantially contribute to the decline in lung function (5-7).”
BackgroundPathogenesis of chronic obstructive pulmonary disease
Tuder, R. M., & Petrache, I. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60324 · Cited by 433
Application of a Neutral Community Model To Assess Structuring of the Human Lung Microbiome
Venkataraman, A., Bassis, C. M., Beck, J. M., Young, V. B., Curtis, J. L., Huffnagle, G. B., & Schmidt, T. M. (2015) · mBio · doi:10.1128/mbio.02284-14 · Cited by 428 · cited 1×
“Recent studies suggest the pulmonary microbiome originates from the dispersal of microbes from the nasal and oral cavities (58, 59).”
BackgroundMolyneaux, P. L., Mallia, P., Cox, M. J., Footitt, J., Willis-Owen, S. A. G., Homola, D., Trujillo-Torralbo, M.-B., Elkin, S., Kon, O. M., Cookson, W. O. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0341oc · Cited by 390 · cited 1×
“A key question still facing the field is where does the airway microbiota originate? (57).”
BackgroundDi Stefano, A., Caramori, G., Gnemmi, I., Contoli, M., Vicari, C., Capelli, A., Magno, F., D'Anna, S. E., Zanini, A., Brun, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03965.x · Cited by 336 · cited 2×
“Increased levels of IL-17A have been implicated in stable COPD (52), and a recent study has shown that the number of CD4+ IL-17A+ cells in the small airways positively correlates with airflow limitation (46).”
BackgroundShaw, M. H., Kamada, N., Kim, Y.-G., & Núñez, G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111703 · Cited by 333 · cited 1×
“Th17 cells (34, 60-62) and exacerbating IL-17 mediated inflammation in experimental autoimmune encephalitis (EAE) and arthritis (34-36).”
BackgroundEffect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Willemse, B. W. M., ten Hacken, N. H. T., Rutgers, B., Lesman-Leegte, I. G. A. T., Postma, D. S., & Timens, W. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00108904 · Cited by 322 · cited 1×
“Moreover whilst smoking cessation does lead to an improvement in lung function in moderate disease, in some cases it does not impact on disease progression (8).”
BackgroundCigarette Smoke–induced Emphysema: A Role for the B Cell?
van der Strate, B. W. A., Postma, D. S., Brandsma, C.-A., Melgert, B. N., Luinge, M. A., Geerlings, M., Hylkema, M. N., van den Berg, A., Timens, W., & Kerstjens, H. A. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-594oc · Cited by 311 · cited 5×
“Further supporting an autoimmune component to disease pathogenesis, lymphoid follicles have consistently been observed in animal models and in humans with COPD (24-27).”
BackgroundMethodInfluentialMurphy, T. F., Brauer, A. L., Grant, B. J. B., & Sethi, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1747oc · Cited by 287
Hypothesis: Does COPD have an autoimmune component?
Agusti, A. (2003) · Thorax · doi:10.1136/thorax.58.10.832 · Cited by 279
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Feghali-Bostwick, C. A., Gadgil, A. S., Otterbein, L. E., Pilewski, J. M., Stoner, M. W., Csizmadia, E., Zhang, Y., Sciurba, F. C., & Duncan, S. R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-014oc · Cited by 269 · cited 4×
“While sequence analysis of B cell clones isolated from LFs in COPD lungs has indicated the presence of an oligoclonal, antigen specific humoral response (25), there are conflicting reports regarding the production of self-reactive antibodies (28-32).”
BackgroundInfluentialLochner, M., Ohnmacht, C., Presley, L., Bruhns, P., Si-Tahar, M., Sawa, S., & Eberl, G. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100052 · Cited by 254 · cited 1×
“Incidentally, cues from the microbiota have been reported to support lymphoid neogenesis(33), the production of self reactive antibodies (34) and are implicated in the pathogenesis of a variety of autoimmune models (34-36).”
BackgroundDuan, J., Chung, H., Troy, E., & Kasper, D. L. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.005 · Cited by 224 · cited 1×
“Th17 cells (34, 60-62) and exacerbating IL-17 mediated inflammation in experimental autoimmune encephalitis (EAE) and arthritis (34-36).”
BackgroundSignificance of the microbiome in obstructive lung disease
Han, M. K., Huang, Y. J., LiPuma, J. J., Boushey, H. A., Boucher, R. C., Cookson, W. O., Curtis, J. L., Erb-Downward, J., Lynch, S. V., Sethi, S., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201183 · Cited by 224 · cited 1×
“Previously considered sterile, breakthroughs in non-culture based detection methods have provided evidence that the respiratory tract harbors a microbiota (9-18).”
BackgroundDestructive index: a measurement of lung parenchymal destruction in smokers.
Saetta, M. P., Shiner, R. J., Angus, G. E., Kim, W. D., Wang, N. S., King, M., Ghezzo, H., & Cosio, M. G. (1985) · PubMed · doi:10.1164/arrd.1985.131.5.764 · Cited by 222
Measurement of pulmonary emphysema.
Wm, T. (1967) · PubMed · doi:10.1164/arrd.1967.95.5.752 · Cited by 211
Kirkham, P. A., Caramori, G., Casolari, P., Papi, A. A., Edwards, M., Shamji, B., Triantaphyllopoulos, K., Hussain, F., Pinart, M., Khan, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1605oc · Cited by 186 · cited 2×
“Conversely self-reactive antibodies, in particular IgG1 isotypes, are more prevalent in severe disease and implicated in pathogenesis (30, 65, 68).”
BackgroundChen, K., Pociask, D. A., McAleer, J. P., Chan, Y. R., Alcorn, J. F., Kreindler, J. L., Keyser, M. R., Shapiro, S. D., Houghton, A. M., Kolls, J. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020333 · Cited by 167 · cited 1×
“Both autoimmune mechanisms and IL-17 (31, 46-54) are implicated in the pathogenesis of COPD.”
BackgroundOligoclonal CD4+ T Cells in the Lungs of Patients with Severe Emphysema
Sullivan, A. K., Simonian, P. L., Falta, M. T., Mitchell, J. D., Cosgrove, G. P., Brown, K. K., Kotzin, B. L., Voelkel, N. F., & Fontenot, A. P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1332oc · Cited by 152 · cited 1×
“Both autoimmune mechanisms and IL-17 (31, 46-54) are implicated in the pathogenesis of COPD.”
BackgroundLymphoid follicles in (very) severe COPD: beneficial or harmful?
Brusselle, G. G., Demoor, T., Bracke, K. R., Brandsma, C.-A., & Timens, W. (2009) · European Respiratory Journal · doi:10.1183/09031936.00150208 · Cited by 151 · cited 3×
“5 Another emerging hypothesis suggests there is an autoimmune component driving the progression of COPD (5, 21, 22).”
BackgroundRole of B Cell–Activating Factor in Chronic Obstructive Pulmonary Disease
Seys, L., Verhamme, F. M., Schinwald, A., Hammad, H., Cunoosamy, D. M., Bantsimba-Malanda, C., Sabirsh, A., McCall, E. J., Flavell, L., Herbst, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0103oc · Cited by 125 · cited 1×
“This could distinguish a subset of COPD patients in whom disease pathogenesis has a clear association with autoimmunity and ultimately identify patients that would benefit the most from treatments targeting B cells(66, 67).”
BackgroundMarsland, B. J., Kurrer, M., Reissmann, R., Harris, N. L., & Kopf, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200737827 · Cited by 116 · cited 2×
“Although neutrophilia waned in the BAL, the continued prevalence of hemosiderin-laden macrophages (P 0.01) was indicative of chronic inflammation and micro-hemorrhaging months after the final challenge (Figure E1D)(42).”
BackgroundInfluentialSelf-citationBracke, K. R., Verhamme, F. M., Seys, L., Bantsimba-Malanda, C., Cunoosamy, D. M., Herbst, R., Hammad, H., Lambrecht, B. N., Joos, G., & Brusselle, G. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2055oc · Cited by 116 · cited 5×
“Further supporting an autoimmune component to disease pathogenesis, lymphoid follicles have consistently been observed in animal models and in humans with COPD (24-27).”
BackgroundMethodInfluentialMorphological and cellular basis for airflow limitation in smokers
Saetta, M., Finkelstein, R., & Cosio, M. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07081505 · Cited by 113 · cited 1×
“Exposure to cigarette smoke is the most widely associated environmental risk factor for the development of the disease(2), which presents as chronic bronchitis and emphysema that lead to progressive and irreversible airflow limitation (3, 4).”
BackgroundZakharkina, T., Heinzel, E., Koczulla, R. A., Greulich, T., Rentz, K., Pauling, J. K., Baumbach, J., Herrmann, M., Grünewald, C., Dienemann, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068302 · Cited by 107 · cited 2×
“Notably, the microbiota in the respiratory tract of healthy volunteers, smokers without COPD and patients with severe disease are distinct (9, 10, 12-14).”
BackgroundElastase- and LPS-exposed mice display altered responses to rhinovirus infection
Sajjan, U. S., Ganesan, S., Comstock, A. T., Shim, J., Wang, Q., Nagarkar, D. R., Zhao, Y., Goldsmith, A. M., Sonstein, J., Linn, M. J., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00150.2009 · Cited by 101 · cited 1×
“We aimed to elucidate the role of the microbiome in COPD using a murine model(37), which mimics key features of human disease.”
BackgroundIs Alveolar Destruction and Emphysema in Chronic Obstructive Pulmonary Disease an Immune Disease?
Taraseviciene-Stewart, L., Douglas, I. S., Nana-Sinkam, P. S., Lee, J. D., Tuder, R. M., Nicolls, M. R., & Voelkel, N. F. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-105sf · Cited by 101 · cited 1×
“Both autoimmune mechanisms and IL-17 (31, 46-54) are implicated in the pathogenesis of COPD.”
BackgroundCui, L., Morris, A., Huang, L., Beck, J. M., Twigg, H. L., von Mutius, E., & Ghedin, E. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201402-052pl · Cited by 100 · cited 1×
“Previously considered sterile, breakthroughs in non-culture based detection methods have provided evidence that the respiratory tract harbors a microbiota (9-18).”
BackgroundPark, H., Shin, J. W., Park, S.-G., & Kim, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109710 · Cited by 100 · cited 4×
“Similarly the relative abundance of Lactobacillus is also increased in asthmatic and COPD patients(43) and an additional study has linked it to COPD severity(10).”
BackgroundResultInfluentialRespiratory microbiota: addressing clinical questions, informing clinical practice
Rogers, G. B., Shaw, D., Marsh, R. L., Carroll, M. P., Serisier, D. J., & Bruce, K. D. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205826 · Cited by 96 · cited 1×
“Previously considered sterile, breakthroughs in non-culture based detection methods have provided evidence that the respiratory tract harbors a microbiota (9-18).”
BackgroundKurimoto, E., Miyahara, N., Kanehiro, A., Waseda, K., Taniguchi, A., Ikeda, G., 古賀, 光., Nishimori, H., Tanimoto, Y., Kataoka, M., et al. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-5 · Cited by 95
The Airway Microbiome and Disease
Marsland, B. J., Yadava, K., & Nicod, L. P. (2013) · CHEST Journal · doi:10.1378/chest.12-2854 · Cited by 77 · cited 1×
“16 microbe interactions localized within a single habitat, such as that found in the lung and skin (55, 56).”
BackgroundSelf-citationSerum Amyloid A Promotes Lung Neutrophilia by Increasing IL-17A Levels in the Mucosa and γδ T Cells
Anthony, D., Seow, H. J., Uddin, M., Thompson, M. A., Dousha, L. F., Vlahos, R., Irving, L. B., Levy, B. D., Anderson, G. P., & Bozinovski, S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2139oc · Cited by 72 · cited 1×
“Both autoimmune mechanisms and IL-17 (31, 46-54) are implicated in the pathogenesis of COPD.”
BackgroundZhang, J., Chu, S., Zhong, X., Lao, Q., He, Z., & Liang, Y. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.10.018 · Cited by 60 · cited 2×
“Increased levels of IL-17A have been implicated in stable COPD (52), and a recent study has shown that the number of CD4+ IL-17A+ cells in the small airways positively correlates with airflow limitation (46).”
BackgroundBonarius, H. P. J., Brandsma, C. A., Kerstjens, H. A. M., Koerts, J. A., Kerkhof, M., Nizankowska-Mogilnicka, E., Roozendaal, C., Postma, D. S., & Timens, W. (2011) · Thorax · doi:10.1136/thx.2009.134171 · Cited by 56 · cited 2×
“While sequence analysis of B cell clones isolated from LFs in COPD lungs has indicated the presence of an oligoclonal, antigen specific humoral response (25), there are conflicting reports regarding the production of self-reactive antibodies (28-32).”
BackgroundFacing a “Slow-Motion Disaster” — The UN Meeting on Noncommunicable Diseases
Rosenbaum, L. R., & Lamas, D. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1112235 · Cited by 52 · cited 2×
“Pulmonary emphysema was quantified by measuring mean linear intercept for airspace enlargement and destruction index for alveolar wall destruction(1, 2).”
BackgroundMethodAntielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease
Rinaldi, M., Lehouck, A., Heulens, N., Lavend'Homme, R., Carlier, V., Saint-Remy, J.-M., Decramer, M., Gayan-Ramirez, G., & Janssens, W. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200690 · Cited by 52 · cited 2×
“While sequence analysis of B cell clones isolated from LFs in COPD lungs has indicated the presence of an oligoclonal, antigen specific humoral response (25), there are conflicting reports regarding the production of self-reactive antibodies (28-32).”
BackgroundPodolin, P. L., Foley, J. P., Carpenter, D. C., Bolognese, B. J., Logan, G. A., Long, E., Harrison, O. J., & Walsh, P. T. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00152.2012 · Cited by 51 · cited 1×
“Both autoimmune mechanisms and IL-17 (31, 46-54) are implicated in the pathogenesis of COPD.”
BackgroundDifferential switching to IgG and IgA in active smoking COPD patients and healthy controls
Brandsma, C.-A., Kerstjens, H. A. M., van Geffen, W. H., Geerlings, M., Postma, D. S., Hylkema, M. N., & Timens, W. (2012) · European Respiratory Journal · doi:10.1183/09031936.00011211 · Cited by 48 · cited 18×
“A significant increase in specific responses against collagen was detected for IgG1, (P 0.01) and IgA (P 0.001) but not IgM isotypes (Figure 2E-G).”
BackgroundInfluentialChryseobacterium respiratory tract infections in patients with cystic fibrosis
Lambiase, A., Pezzo, M. D., Raia, V., Sepe, A. O., Ferri, P., & Rossano, F. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.08.002 · Cited by 47 · cited 6×
“On the contrary, relative abundance of Pseudomonas, Lactobacillus and Chryseobacterium was increased in the BAL of LPS/Elastase Copyright © 2015 by the American Thoracic Society 13 treated mice.”
ResultInfluentialAnti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema: Fig. 1—
Cottin, V., Fabien, N., Khouatra, C., Moreira, A., & Cordier, J.-F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00140208 · Cited by 46 · cited 2×
“While sequence analysis of B cell clones isolated from LFs in COPD lungs has indicated the presence of an oligoclonal, antigen specific humoral response (25), there are conflicting reports regarding the production of self-reactive antibodies (28-32).”
BackgroundEppert, B. L., Wortham, B. W., Flury, J. L., & Borchers, M. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202442 · Cited by 46 · cited 1×
“Both autoimmune mechanisms and IL-17 (31, 46-54) are implicated in the pathogenesis of COPD.”
BackgroundMori, M., Andersson, C. K., Svedberg, K., Glader, P., Bergqvist, A., Shikhagaie, M., Löfdahl, C., & Erjefalt, J. S. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202879 · Cited by 45 · cited 3×
“Chronic pulmonary inflammation is associated with lymphoid neogenesis, enhanced local antibody responses and IL-17A production In line with previous data in human disease and animal models of CS induced emphysema, (24-27), we observed the formation of lymphoid follicles (LFs) which could be categorized as bronchiolar…”
BackgroundColonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients
Engler, K., Mühlemann, K., Garzoni, C., Pfahler, H., Geiser, T., & von Garnier, C. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13509 · Cited by 37 · cited 1×
“Consistently Pseudomonas is increased in asthmatic and COPD patients(43), and its presence correlates with COPD severity(44).”
BackgroundJTD special edition 'Hot Topics in COPD'-The microbiome in COPD.
Chambers, D. C., Gellatly, S. L., Hugenholtz, P., & Hansbro, P. M. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.11.08 · Cited by 25 · cited 1×
“Previously considered sterile, breakthroughs in non-culture based detection methods have provided evidence that the respiratory tract harbors a microbiota (9-18).”
BackgroundLymphoid follicles in chronic lung diseases
Yadava, K., & Marsland, B. J. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-203008 · Cited by 21 · cited 1×
“However self-antigens derived from the collateral damage of the lung tissue might also be presented within LFs and result in the production of autoantibodies (22, 64).”
BackgroundSelf-citationThe Microbiota in Respiratory Disease
Erb‐Downward, J. R., Huffnagle, G. B., & Martínez, F. J. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0567ed · Cited by 15 · cited 2×
“Notably, the microbiota in the respiratory tract of healthy volunteers, smokers without COPD and patients with severe disease are distinct (9, 10, 12-14).”
Background“B” for Bad, Beneficial, or Both? Lung Lymphoid Neogenesis in Chronic Obstructive Pulmonary Disease
Curtis, J. L., Freeman, C. M., & Huffnagle, G. B. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1230ed · Cited by 13 · cited 1×
“This could distinguish a subset of COPD patients in whom disease pathogenesis has a clear association with autoimmunity and ultimately identify patients that would benefit the most from treatments targeting B cells(66, 67).”
Background
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
The immune response to Prevotella bacteria in chronic inflammatory disease
Larsen, J. M. (2017) · Immunology · doi:10.1111/imm.12760 · Cited by 1,343
The respiratory tract microbiome and lung inflammation: a two-way street.
Huffnagle, G. B., Dickson, R. P., & Lukacs, N. W. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.108 · Cited by 535
“and intranasal transfer of bronchoalveolar lavage fluid that contains the lung microbiota from these diseased mice enhances IL-17A production in the lungs of antibiotic-treated or germ-free recipients.(54) This is consistent with the findings that targeting of the lung microbiota by innate immunity, as a result of pIg…”
ResultLung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
O’Dwyer, D. N., Ashley, S. L., Gurczynski, S. J., Xia, M., Wilke, C., Falkowski, N. R., Norman, K. C., Arnold, K. B., Huffnagle, G. B., Salisbury, M. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1650oc · Cited by 366
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362
“(121) reported the impact of experimental change on the lung microbiota in an emphysema animal model.”
Background
Metadata
- Authors
- Yadava, K., Pattaroni, C., Sichelstiel, A. K., Trompette, A., Gollwitzer, E. S., Salami, O., von Garnier, C., Nicod, L. P., & Marsland, B. J.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Department of Respiratory Medicine, Inselspital, Bern University Hospital, Bern, Switzerland; and
- Corresponding author
- Yadava, Koshika
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05-01
- Volume
- 193
- Issue
- 9
- Pages
- 975-987
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2186872267
- Cited by
- 184
- References
- 70
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 24 · 2023: 22 · 2022: 36 · 2021: 15 · 2020: 15 · 2019: 12 · 2018: 14 · 2017: 17 · 2016: 10
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- green
- boris.unibe.ch
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, other-oa)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Open Access CRIS of the University of Bern
- Funders
- National Science Foundation (CRSII3_141875)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- pulmonary microbiota, chronic lung inflammation, IL-17A, autoantibodies, chronic obstructive pulmonary disease, microbiota depletion, germ-free mice, Pseudomonas, Lactobacillus, Prevotella, lymphoid neogenesis, lung function
- MeSH terms
- Animals, Autoantibodies, Disease Models, Animal, Inflammation, Lung, Mice, Inbred BALB C, Interleukin-17, Pulmonary Disease, Chronic Obstructive, Mice, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.